Bionaut Labs
Precision-targeted Medicine Modality for CNS Disorders
Company Overview
Snapshot
Founded in January 2016 by Aviad Maizels, Michael Shpigelmacher, and Alexander Shpunt, Bionaut Labs operates with 11–50 employees. The company has raised $69.2M across 3 funding rounds from 15 investors. In February 2024, Bionaut Labs secured an extension round of funding, preparing for micro-robot clinical trials.
Business overview
Bionaut Labs is a biotechnology startup developing a precision medicine treatment modality for central nervous system (CNS) disorders. The company utilizes remote-controlled microscale robots, called Bionauts, to deliver biologics, nucleic acids, or small molecule therapies directly to targeted CNS disease areas. This approach aims to enhance efficacy and safety compared to traditional treatment methods. Bionaut Labs is initially focusing on indications such as gliomas and Huntington's disease, operating within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drug Delivery.
Strategic signal
Bionaut Labs' February 2024 extension funding round, specifically aimed at preparing for micro-robot clinical trials, signals a critical advancement towards clinical validation and commercialization. This development indicates strong investor confidence in their innovative drug delivery platform and suggests the company is moving closer to bringing its precision-targeted therapies for CNS disorders to market, potentially disrupting traditional treatment paradigms.
Log in to access full profile ›Company Intelligence Q&A
- What is Bionaut Labs' core technology?
- Bionaut Labs develops precision medicine using remote-controlled microscale robots, called Bionauts, to deliver therapies directly to targeted central nervous system (CNS) disease areas.
- When was Bionaut Labs founded and by whom?
- Bionaut Labs was founded in January 2016 by Aviad Maizels, Michael Shpigelmacher, and Alexander Shpunt.
- What significant funding event occurred in February 2024?
- In February 2024, Bionaut Labs raised an extension round of funding, with participation from OurCrowd.
- Which investors participated in the November 2022 funding round?
- In November 2022, Khosla Ventures led a funding round for.
- What was a key development for Bionaut Labs in March 2021?
- In March 2021, Bionaut Labs exited stealth mode after securing a funding round led by.